Your browser doesn't support javascript.
loading
Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-ß/IL-6 pathway in neuroblastoma.
Louault, Kevin; Porras, Tania; Lee, Meng-Hua; Muthugounder, Sakunthala; Kennedy, Rebekah J; Blavier, Laurence; Sarte, Emily; Fernandez, G Esteban; Yang, Fusheng; Pawel, Bruce R; Shimada, Hiroyuki; Asgharzadeh, Shahab; DeClerck, Yves A.
Affiliation
  • Louault K; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Porras T; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Lee MH; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Muthugounder S; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Kennedy RJ; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Blavier L; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Sarte E; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • Fernandez GE; The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Yang F; Department of Pathology, University of Southern California, Los Angeles, CA, USA.
  • Pawel BR; Department of Pathology, University of Southern California, Los Angeles, CA, USA.
  • Shimada H; Departments of Pathology and Pediatrics, Stanford University, Stanford, CA, USA.
  • Asgharzadeh S; Cancer and Blood Diseases Institute, Department of Pediatrics, Children's Hospital Los Angeles and the University of Southern California, Los Angeles, CA, USA.
  • DeClerck YA; Department of Pathology, University of Southern California, Los Angeles, CA, USA.
Oncoimmunology ; 11(1): 2146860, 2022.
Article in En | MEDLINE | ID: mdl-36479153
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Transforming Growth Factor beta1 / Fibroblasts / Macrophages / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncoimmunology Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Transforming Growth Factor beta1 / Fibroblasts / Macrophages / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncoimmunology Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States